117 Ps developed AKI.
Sex distribution: 78 men (66.6%) and 39 women (33.3%); average age: 58.17 years (19‑90); overall mortality rate: 50.42% (59 Ps).
50 Ps had comorbidities and 12 Ps were kidney transplant recipients.
The causes of AKI: sepsis: 63.2% (n: 74); cardio-renal: 20.5% (n: 20); obstructive: 8.5% (n: 10); nephrotoxic: 5.9% (n: 7); and rhabdomyolysis: 1.7% (n:2).
Regarding the type of renal replacement therapy, 114 of 117 Ps received renal replacement therapy. Of them, 90% received intermittent hemodialysis; 30%, continuous venovenous hemodiafiltration; and 30%, SLEDD.
In slow continuous therapies, the average dialysis time was 33.3 hrs (4-72).
Average number of hemodialysis sessions: 6.58 (1-21).
The overall mortality rate in our study was 50.4% (n: 59). Recovery from AKI was 32% (n: 38)
When comparing the groups of deceased and survivors, age was 64 vs. 52.8 (p<0.05) and there were no gender differences (39 M vs. 20 F).
In terms of comorbidities, the deceased Ps had more history of heart disease (25 vs. 14, p<0.05), and there were no differences in terms of HBP, DM, obesity and CKD not going on dialysis.
As regards the cause of AKI, sepsis was observed in 39 of the deceased Ps vs. 26 of the surviving Ps (p<0.05), and there were no differences in terms of other causes of AKI.
ICU admission and mechanical ventilation requirements in deceased and surviving groups: 55 vs. 39 (p<0.05) and 55 vs. 28 (p<0.05), respectively.
Of the 58 survivors, 34 (58.6%) recovered their renal function and 24 (41.4%) remained on dialysis. Comparing the Ps remaining on dialysis and those recovering, there was a history of CKD in 19/24 (79%) in the former, and in 10/34 (29.4%) (p<0.05) in the latter.